31
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Klebsiella bacteremia: A review of 196 episodes during a decade (1980–1989)

&
Pages 399-405 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ferran Llopis, Imma Grau, Fe Tubau, Maria Cisnal & Roman Pallares. (2004) Epidemiological and Clinical Characteristics of Bacteraemia Caused by Aeromonas spp. as Compared with Escherichia coli and Pseudomonas aeruginosa. Scandinavian Journal of Infectious Diseases 36:5, pages 335-341.
Read now
Gitte Pedersen, Henrik Carl Schønheyder & Henrik Toft Sørensen. (1997) Antibiotic Therapy and Outcome of Monomicrobial Gram-negative Bacteraemia: A 3-year population-based study. Scandinavian Journal of Infectious Diseases 29:6, pages 601-606.
Read now
Chatrchai Watanakunakorn & Sriram C. Perni. (1994) Proteus mirabilis Bacteremia: A Review of 176 Cases During 1980–1992. Scandinavian Journal of Infectious Diseases 26:4, pages 361-367.
Read now
Chatrchai Watanakunakorn & James Pantelakis. (1993) Alpha-hemolytic Streptococcal Bacteremia: A Review of 203 Episodes during 1980–1991. Scandinavian Journal of Infectious Diseases 25:4, pages 403-408.
Read now

Articles from other publishers (26)

Agata Palusiak. (2022) Proteus mirabilis and Klebsiella pneumoniae as pathogens capable of causing co-infections and exhibiting similarities in their virulence factors. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Ping Li, Yangheng Zhang, Fuhua Yan & Xin Zhou. (2021) Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia. Frontiers in Microbiology 12.
Crossref
Nakul Neog, Upasana Phukan, Minakshi Puzari, Mohan Sharma & Pankaj Chetia. (2021) Klebsiella oxytoca and Emerging Nosocomial Infections. Current Microbiology 78:4, pages 1115-1123.
Crossref
Taruna Anand, Nitin Virmani, Sudarshan Kumar, Ashok Kumar Mohanty, S. Pavulraj, Bidhan Ch. Bera, Rajesh K. Vaid, Umang Ahlawat & B.N. Tripathi. (2020) Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. Journal of Global Antimicrobial Resistance 21, pages 34-41.
Crossref
Chih-Han Juan, Chien Chuang, Chi-Han Chen, Lo Li & Yi-Tsung Lin. (2019) Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Chun Kit Li, Oi Fung Wong, Shing Ko, Hing Man Ma & Chau Hung Albert Lit. (2018) A preliminary report of clinical experience in managing patients with sepsis and septic shock in emergency medicine ward. Hong Kong Journal of Emergency Medicine 26:1, pages 15-25.
Crossref
P. Warnke, V. Kiefel, H. Schäffler & A. Podbielski. (2013) Transfusion reaction due to Klebsiella pneumoniae -contaminated red blood cells: a case report . Transfusion Medicine 23:6, pages 445-446.
Crossref
Younghee Jung, Myung Jin Lee, Hye-Yun Sin, Nak-Hyun Kim, Jeong-Hwan Hwang, Jinyong Park, Pyoeng Gyun Choe, Wan Beom Park, Eu Suk Kim, Sang-Won Park, Kyoung Un Park, Hong Bin Kim, Nam-Joong Kim, Eui-Chong Kim, Kyoung-Ho Song & Myoung-don Oh. (2012) Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea. BMC Infectious Diseases 12:1.
Crossref
Kerri A Thom, Marin L Schweizer, Regina B Osih, Jessina C McGregor, Jon P Furuno, Eli N Perencevich & Anthony D Harris. (2008) Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study. BMC Infectious Diseases 8:1.
Crossref
Kerri A. Thom, Michelle D. Shardell, Regina B. Osih, Marin L. Schweizer, Jon P. Furuno, Eli N. Perencevich, Jessina C. McGregor & Anthony D. Harris. (2015) Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points. Infection Control & Hospital Epidemiology 29:11, pages 1048-1053.
Crossref
Fadi Braiteh & Marjorie P. Golden. (2007) Cryptogenic invasive Klebsiella pneumoniae liver abscess syndrome. International Journal of Infectious Diseases 11:1, pages 16-22.
Crossref
Maria Silvana Alves, Rubens Clayton da Silva Dias, Angela Christina Dias de Castro, Lee W. Riley & Beatriz Meurer Moreira. (2006) Identification of Clinical Isolates of Indole-Positive and Indole-Negative Klebsiella spp . Journal of Clinical Microbiology 44:10, pages 3640-3646.
Crossref
Dieter A. Stürchler. 2006. Exposure. Exposure 605 868 .
Manette T. Niu, Maureen Knippen, Lois Simmons & Leslie G. Holness. (2006) Transfusion-Transmitted Klebsiella pneumoniae Fatalities, 1995 to 2004. Transfusion Medicine Reviews 20:2, pages 149-157.
Crossref
Cheol In KangSung Han KimJi Whan BangHong Bin KimNam Joong KimEui Chong KimMyoung Don OhKang Won Choe. (2006) Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance. Journal of Korean Medical Science 21:5, pages 816.
Crossref
Cheol-In Kang, Sung-Han Kim, Dong Min Kim, Wan Beom Park, Ki-Deok Lee, Hong-Bin Kim, Myoung-don Oh, Eui-Chong Kim & Kang-Won Choe. (2015) Risk Factors for and Clinical Outcomes of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae . Infection Control & Hospital Epidemiology 25:10, pages 860-867.
Crossref
Anucha Apisarnthanarak, Galit Holzmann-Pazgal, Aaron Hamvas, Margaret A. Olsen & Victoria J. Fraser. (2015) Antimicrobial Use and the Influence of Inadequate Empiric Antimicrobial Therapy on the Outcomes of Nosocomial Bloodstream Infections in a Neonatal Intensive Care Unit. Infection Control & Hospital Epidemiology 25:9, pages 735-741.
Crossref
Dennis S. Hansen, Hazel M. Aucken, Titi Abiola & Rainer Podschun. (2004) Recommended Test Panel for Differentiation of Klebsiella Species on the Basis of a Trilateral Interlaboratory Evaluation of 18 Biochemical Tests . Journal of Clinical Microbiology 42:8, pages 3665-3669.
Crossref
Carsten Struve & Karen Angeliki Krogfelt. (2004) Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environmental Microbiology 6:6, pages 584-590.
Crossref
Leibovici Shraga Drucker Konigsberger Samra, Pitlik Pitlik. (2002) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. Journal of Internal Medicine 244:5, pages 379-386.
Crossref
D.Schrøder Hansen, A. Gottschau & H.Jørn Kolmos. (1998) Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control. Journal of Hospital Infection 38:2, pages 119-132.
Crossref
M. P. Weinstein, M. L. Towns, S. M. Quartey, S. Mirrett, L. G. Reimer, G. Parmigiani & L. Barth Reller. (1997) The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults. Clinical Infectious Diseases 24:4, pages 584-602.
Crossref
Melvin P. Weinstein, Michael L. Towns, Seth M. Quartey, Stanley Mirrett, Larry G. Reimer, Giovanni Parmigiani & L. Barth Reller. (1997) The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults. Clinical Infectious Diseases 24:4, pages 584-602.
Crossref
K.H. Lee, K.P. Hui, W.C. Tan & T.K. Lim. (1994) Klebsiella bacteraemia: a report of 101 cases from National University Hospital, Singapore. Journal of Hospital Infection 27:4, pages 299-305.
Crossref
J.M.T. Hamilton-Miller. (1993) Continuing the Search for Bacterial Urovirulence Factors. Zentralblatt für Bakteriologie 279:2, pages 147-153.
Crossref
V. Vernet, C. Madoulet, C. Chippaux & A. Philippon. (1992) Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamase . FEMS Microbiology Letters 96:1, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.